IDEXX Laboratories (WBO:IDXX) COGS-to-Revenue : 0.42 (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is IDEXX Laboratories COGS-to-Revenue?

IDEXX Laboratories's Cost of Goods Sold for the three months ended in Dec. 2023 was €344 Mil. Its Revenue for the three months ended in Dec. 2023 was €827 Mil.

IDEXX Laboratories's COGS to Revenue for the three months ended in Dec. 2023 was 0.42.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. IDEXX Laboratories's Gross Margin % for the three months ended in Dec. 2023 was 58.36%.

IDEXX Laboratories COGS-to-Revenue Historical Data

The historical data trend for IDEXX Laboratories's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IDEXX Laboratories COGS-to-Revenue Chart

IDEXX Laboratories Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.43

0.42

0.41

0.40

IDEXX Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial															0.41	0.40	0.39	0.40	0.42

IDEXX Laboratories COGS-to-Revenue Calculation

IDEXX Laboratories's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	1348.892	/	3357.094
	=	0.40

IDEXX Laboratories's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	344.273	/	826.768
	=	0.42

IDEXX Laboratories (WBO:IDXX) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

IDEXX Laboratories's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	344.273 / 826.768
	=	58.36 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

IDEXX Laboratories COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of IDEXX Laboratories's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

IDEXX Laboratories (WBO:IDXX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IDEXX Laboratories Inc (WBO:IDXX) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

IDXX:USA IDXX:Mexico IX1:Germany I1DX34:Brazil

Address

One IDEXX Drive, Westbrook, ME, USA, 04092

Website

https://www.idexx.com

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 40% of its revenue from outside the United States.